NCT00847886View on ClinicalTrials.gov

Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

LX3305

Daily oral intake of LX3305 for 14 days.

DRUG

LX3305 Placebo

Matching placebo dosing with daily oral intake for 14 days.

DRUG

Methotrexate

Once weekly stable-dose methotrexate.

Trial Locations (1)

75235

Metroplex Clinical Research Center, Dallas

Sponsors
All Listed Sponsors
lead

Lexicon Pharmaceuticals

INDUSTRY